{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:15:15Z","timestamp":1780672515979,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T00:00:00Z","timestamp":1416441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s12519-014-0517-6","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T12:42:05Z","timestamp":1416573725000},"page":"226-231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Growth patterns in children with mucopolysaccharidosis I and II"],"prefix":"10.1007","volume":"11","author":[{"given":"Agnieszka","family":"R\u00f3\u017cd\u017cy\u0144ska-\u015awi\u0105tkowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Jurecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Cie\u015blik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tylki-Szyma\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,20]]},"reference":[{"key":"517_CR1","first-page":"3421","volume-title":"The metabolic and molecular basis of inherited disease","author":"EF Neufeld","year":"2001","unstructured":"Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, eds. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill, 2001: 3421\u20133452."},{"key":"517_CR2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ajmg.1320200308","volume":"20","author":"M Roubicek","year":"1985","unstructured":"Roubicek M, Gehler J, Spranger J. The clinical spectrum of alpha-L-iduronidase deficiency. Am J Med Genet 1985;20:471\u2013481.","journal-title":"Am J Med Genet"},{"key":"517_CR3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/peds.2007-3847","volume":"123","author":"LA Clarke","year":"2009","unstructured":"Clarke LA, Wraith JE, Beck M, Kolodny EH, Pastores GM, Muenzer J, et al. Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I. Pediatrics 2009;123:229\u2013240.","journal-title":"Pediatrics"},{"key":"517_CR4","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1007\/978-1-4419-1795-9_126","volume-title":"Handbook of growth and growth monitoring in health and disease","author":"S Tomatsu","year":"2012","unstructured":"Tomatsu S, Montano AM, Oikawa H, Giugliani R, Harmatz P, Smith M, et al. Impairment of body growth in mucopolysaccharidoses. In: Preedy VR, eds. Handbook of growth and growth monitoring in health and disease New York: Springer, 2012: 2091\u20132116."},{"key":"517_CR5","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.bbadis.2011.07.013","volume":"1812","author":"E Oussoren","year":"2011","unstructured":"Oussoren E, Brands MM, Ruijter GJ, der Ploeg AT, Reuser AJ. Bone, joint and tooth development in mucopolysaccharidoses: Relevance to therapeutic options. Biochim Biophys Acta 2011;1812:1542\u20131556.","journal-title":"Biochim Biophys Acta"},{"key":"517_CR6","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0002-9440(10)64961-9","volume":"156","author":"A Hinek","year":"2000","unstructured":"Hinek A, Wilson SE. Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastinbinding protein and elastic fiber assembly. Am J Patho 2000;156:925\u2013938.","journal-title":"Am J Patho"},{"key":"517_CR7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1203\/01.PDR.0000156510.96253.5A","volume":"57","author":"CM Simonaro","year":"2005","unstructured":"Simonaro CM, D\u2019Angelo M, Haskins ME, Schuchman EH. Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models. Pediatr Res 2005;57:701\u2013707.","journal-title":"Pediatr Res"},{"key":"517_CR8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2353\/ajpath.2008.070564","volume":"172","author":"CM Simonaro","year":"2008","unstructured":"Simonaro CM, D\u2019Angelo M, He X, Eliyahu E, Shtraizent N, Haskins ME, et al. Mechanism of glycosaminoglycanmediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases. Am J Pathol 2008;172:112\u2013122.","journal-title":"Am J Pathol"},{"key":"517_CR9","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/labinvest.3780345","volume":"81","author":"CM Simonaro","year":"2001","unstructured":"Simonaro CM, Haskins ME, Schuchman EH. Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: a possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses. Lab invest 2001;81:1319\u20131328.","journal-title":"Lab invest"},{"key":"517_CR10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajmg.a.30579","volume":"134","author":"SJ Swiedler","year":"2005","unstructured":"Swiedler SJ, Beck M, Bajbouj M, Giugliani R, Schwartz I, Harmatz P, et al. Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). Am J Med Genet A 2005;134:144\u2013150.","journal-title":"Am J Med Genet A"},{"key":"517_CR11","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/ajmg.a.32281","volume":"146","author":"AM Montano","year":"2008","unstructured":"Montano AM, Tomatsu S, Brusius A, Smith M, Orii T. Growth charts for patients affected with Morquio A disease. Am J Med Genet A 2008;146:1286\u20131295.","journal-title":"Am J Med Genet A"},{"key":"517_CR12","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1651-2227.2010.02060.x","volume":"100","author":"A Rozdzynska","year":"2011","unstructured":"Rozdzynska A, Tylki-Szymanska A, Jurecka A, Cieslik J. Growth pattern and growth prediction of body height in children with mucopolysaccharidosis type II. Acta Paediatr 2011;100:456\u2013460.","journal-title":"Acta Paediatr"},{"key":"517_CR13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ymgme.2013.03.001","volume":"109","author":"SA Jones","year":"2013","unstructured":"Jones SA, Parini R, Harmatz P, Giugliani R, Fang J, Mendelsohn NJ. The effect of idursulfase on growth in patients with Hunter syndrome: data from the Hunter Outcome Survey (HOS). Mol Genet Metab 2013;109:41\u201348.","journal-title":"Mol Genet Metab"},{"key":"517_CR14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10545-010-9215-2","volume":"34","author":"G Schulze-Frenking","year":"2011","unstructured":"Schulze-Frenking G, Jones SA, Roberts J, Beck M, Wraith JE. Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II. J Inherit Metab Dis 2011;34:203\u2013208.","journal-title":"J Inherit Metab Dis"},{"key":"517_CR15","doi-asserted-by":"crossref","first-page":"85074","DOI":"10.1371\/journal.pone.0085074","volume":"9","author":"Z Zuber","year":"2014","unstructured":"Zuber Z, Rozdzynska-Swiatkowska A, Jurecka A, Tylki-Szymanska A. The effect of recombinant human iduronate-2-sulfatase (Idursulfase) on growth in young patients with mucopolysaccharidosis type II. PLoS One 2014;9: 85074.","journal-title":"PLoS One"},{"key":"517_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00439-006-0280-4","volume":"121","author":"M Beck","year":"2007","unstructured":"Beck M. New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy. Hum Genet 2007;121:1\u201322.","journal-title":"Hum Genet"},{"key":"517_CR17","first-page":"18","volume":"5","author":"I Palczewska","year":"2001","unstructured":"Palczewska I, Niedzwiedzka Z. Somatic development indices in children and youth of Warsaw. Med Wieku Rozwoj 2001;5:18\u2013118. [In Polish]","journal-title":"Med Wieku Rozwoj"},{"key":"517_CR18","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/nature05817","volume":"446","author":"JR Bishop","year":"2007","unstructured":"Bishop JR, Schuksz M, Esko JD. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 2007;446:1030\u20131037.","journal-title":"Nature"},{"key":"517_CR19","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10545-010-9199-y","volume":"33","author":"MJ Valstar","year":"2010","unstructured":"Valstar MJ, Bruggenwirth HT, Olmer R, Wevers RA, Verheijen FW, Poorthuis BJ, et al. Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype. J Inherit Metab Dis 2010;33:759\u2013767.","journal-title":"J Inherit Metab Dis"},{"key":"517_CR20","volume-title":"An atlas of clinical syndromes, A visual aid to diagnosis","author":"HR Wiedemann","year":"1992","unstructured":"Wiedemann HR, Kunze J, Dibbern H. An atlas of clinical syndromes, A visual aid to diagnosis, 2nd ed. St Louis: Wolfe Publishing Ltd, 1992.","edition":"2"},{"key":"517_CR21","volume-title":"Lysosomal storage diseases: biochemical and clinical aspects","author":"RWE Watts","year":"1986","unstructured":"Watts RWE, Gibbs DA. Lysosomal storage diseases: biochemical and clinical aspects. (London: Taylor and Francis, 1986."},{"key":"517_CR22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1651-2227.2007.00212.x","volume":"96","author":"IV Schwartz","year":"2007","unstructured":"Schwartz IV, Ribeiro MG, Mota JG, Toralles MB, Correia P, Horovitz D, et al. A clinical study of 77 patients with mucopolysaccharidosis type II. Acta Paediatr 2007;96:63\u201370.","journal-title":"Acta Paediatr"},{"key":"517_CR23","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/adc.57.11.828","volume":"57","author":"ID Young","year":"1982","unstructured":"Young ID, Harper PS. Mild form of Hunter\u2019s syndrome: clinical delineation based on 31 cases. Arch Dis Child 1982;57:828\u2013836.","journal-title":"Arch Dis Child"},{"key":"517_CR24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1542\/peds.2008-0416","volume":"123","author":"J Muenzer","year":"2009","unstructured":"Muenzer J, Wraith JE, Clarke LA. Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics 2009;123:19\u201329.","journal-title":"Pediatrics"},{"key":"517_CR25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","volume":"167","author":"JE Wraith","year":"2007","unstructured":"Wraith JE, Scarpa M, Beck M, Bodamer OA, Meirleir L, Guffon N, et al. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur J Pediatr 2007;167:267\u2013277.","journal-title":"Eur J Pediatr"},{"key":"517_CR26","volume-title":"Rozw\u00f3j w okresie pokwitania","author":"JM Tanner","year":"1963","unstructured":"Tanner JM. Rozw\u00f3j w okresie pokwitania. Warsaw: PZWL, 1963."},{"key":"517_CR27","first-page":"383","volume-title":"Human growth and development","author":"TJ Cole","year":"2006","unstructured":"Cole TJ. Growth references and standards. In: Cameron N, eds. Human growth and development. San Diego: Academic Press, 2006: 383\u2013413."}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-014-0517-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12519-014-0517-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-014-0517-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T17:03:26Z","timestamp":1559581406000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12519-014-0517-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,20]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["517"],"URL":"https:\/\/doi.org\/10.1007\/s12519-014-0517-6","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,20]]}}}